Restless Legs Syndrome Therapeutics
Clinical Trials, Central and South America, Top Countries, 2014* 14
But this publication must be considered as a real landmark for anyone interested in the young history of therapeutics
, especially among French scholars.
We are very pleased to be starting this new clinical trial in ALS with ExonHit Therapeutics
as this study offers hope of further progress in treating this devastating disorder," said Professor P.
Data and analysis for the oncology therapeutics
market in India - Annualized market data for the oncology therapeutics
market in India from 2004 to 2011, with forecasts to 2018 - Key drivers and restraints that have had a significant impact on the market - The competitive landscape of the oncology therapeutics
market in India - Key M&A activities and licensing agreements that have taken place in the Indian oncology therapeutics
We believe that our collaboration with Medarex provides an enabling path forward in the development of advanced treatments for central nervous system injuries," said John Steeves, President of Neuro Therapeutics
is working to expand its zileuton franchise by developing a twice daily, controlled-release formulation for the prevention and chronic treatment of asthma and an intravenous formulation for acute asthma attacks that lead patients to the emergency room and other urgent care settings.
Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Methicillin-Resistant Staphylococcus Aureus (MRSA) Therapeutics
market revenues data from 2006 to 2011, forecast for eight years to 2019.
is an emerging specialty pharmaceutical company developing and commercializing products based on a new transdermal patch technology that can deliver sustained therapeutic
levels of highly water-soluble drugs, carbohydrates, nucleic acids, peptides and proteins through the skin in a convenient, painless, and cost-effective manner.
GBI Research finds that the substance abuse therapeutics
market in the top seven markets was valued at $8.
Autoimmune Disease Therapeutics
Market to Gain from Increased Acceptance of Biologics by Physicians
2 List of Figures 6 2 Methicillin - resistant Staphylococcus aureus (MRSA) Therapeutics
- Introduction 8 2.
GBI Research's new report, "Arthritis Therapeutics
Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications", provides an expert insight into the global arthritis market and market forecast until 2018.